Cancer Immunotherapy News and Research

RSS
Scientists find new way to re-engineer body’s immune system to target cancer

Scientists find new way to re-engineer body’s immune system to target cancer

SillaJen reports initiation of multinational randomized Phase 3 study of Pexa-Vec in HCC patients

SillaJen reports initiation of multinational randomized Phase 3 study of Pexa-Vec in HCC patients

UCL Cancer Institute win $200,000 CytoFLEX Flow Cytometer from Beckman Coulter

UCL Cancer Institute win $200,000 CytoFLEX Flow Cytometer from Beckman Coulter

Viralytics announces completion of $28 million placement

Viralytics announces completion of $28 million placement

ImmunoCellular partners with CBTC for ICT-107 phase 3 registrational trial in patients with glioblastoma

ImmunoCellular partners with CBTC for ICT-107 phase 3 registrational trial in patients with glioblastoma

Crucial tumor-suppressing gene protects immune attack against lung cancer

Crucial tumor-suppressing gene protects immune attack against lung cancer

Researchers identify new target for novel immune-oncology treatments

Researchers identify new target for novel immune-oncology treatments

Loyola and Notre Dame researchers report promising new approaches to treating cancer

Loyola and Notre Dame researchers report promising new approaches to treating cancer

Viralytics enters into clinical trial collaboration agreement with MSD

Viralytics enters into clinical trial collaboration agreement with MSD

Specific gut bacteria can improve cancer immunotherapy, show studies

Specific gut bacteria can improve cancer immunotherapy, show studies

MD Anderson Cancer Center, CytomX to study probody-enabled CAR-NK cell therapies

MD Anderson Cancer Center, CytomX to study probody-enabled CAR-NK cell therapies

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

Virginia Tech researchers study how specific cytokine influences gene expression patterns in T helper cells

Virginia Tech researchers study how specific cytokine influences gene expression patterns in T helper cells

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

Special CD4+ T cells appear to inhibit cancer growth, enhance tumor-killing powers of other immune cells

New research raises hope for novel cancer immunotherapy

New research raises hope for novel cancer immunotherapy

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Genocea announces positive data in Phase 2 trial evaluating GEN-003 for the treatment of genital herpes

Leading cancer researchers address eight 'big questions'

Leading cancer researchers address eight 'big questions'

UCSF researchers develop molecular 'on switch' that allows control over the actions of T cells

UCSF researchers develop molecular 'on switch' that allows control over the actions of T cells

BGB324 shows enhanced tumour clearance in mouse carcinoma models

BGB324 shows enhanced tumour clearance in mouse carcinoma models

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.